Clinical Trials Arena·3 min read·medium
Moderna kicks off Phase I Ebola trial as Africa readies itself for research
A
Abigail Beaney
✦AI Summary
Moderna has launched a Phase I clinical trial for its mRNA-1469 vaccine candidate, which targets the Bundibugyo Ebola virus. The study, supported by the Coalition for Epidemic Preparedness Innovations, aims to evaluate the vaccine's safety and immunogenicity in healthy adults.
If the Phase I trial is successful, Moderna plans to quickly initiate Phase II and Phase III trials of its Ebola vaccine.
healthsciencebusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in